Lifecare
Developing the worlds first long term implantable micro sensor for Continuous Glucose Monitoring.
Developing the worlds first long term implantable micro sensor for Continuous Glucose Monitoring.
Lifecare is a biotechnology company headquartered in Norway, founded in 1996. The company's slogan, "Developing the world's first long-term implantable micro sensor for Continuous Glucose Monitoring", reflects its focus on developing miniaturized and implantable nanobiosensors for continuous monitoring of glucose and other biomarkers. Lifecare also licenses a nanosensor technology for medical use to other companies, facilitating the production and sales of medical devices. The last recorded investment in Lifecare was a €50.00K grant investment from the EASME - EU Executive Agency for SMEs in August 2016. Lifecare's innovative technology has the potential to enhance medical products by incorporating sensing functionalities into devices across all medical indications.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | €50.00K | 1 | EASME - EU Executive Agency for SMEs | 01 Aug 2016 |
No recent news or press coverage available for Lifecare.
We care about your data, and we'd love to use cookies make your experience better.
